Buchumschlag

Engagement and predictors of use of a smartphone app for migraine self‐management: A secondary analysis of the EMMA trial

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Stefanie Lysk, Daniel Pach, Tatjana Tissen‐Diabaté, Simon Scholler, Claudia M. Witt
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Headache: The Journal of Head and Face Pain
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

The effect of vestibular rehabilitation in the management of vestibular migraine in adults: A systematic review and meta‐analysis
von: Jad El Ahdab, et al.
Veröffentlicht: (2025)

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
von: Muneto Tatsumoto, et al.
Veröffentlicht: (2024)

Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy ( MOTS ) trial
von: Samantha C. Shao, et al.
Veröffentlicht: (2024)

A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
von: Jeffrey D. Sharon, et al.
Veröffentlicht: (2024)

Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial
von: Ghader Mohammadnezhad, et al.
Veröffentlicht: (2024)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
von: Shuu‐Jiun Wang, et al.
Veröffentlicht: (2024)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
von: Graham A. McLeod, et al.
Veröffentlicht: (2025)

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department
von: Geneviève Tourigny‐Ruel, et al.
Veröffentlicht: (2026)

A retrospective analysis of the use of candesartan for migraine prevention in adolescents
von: Irene Patniyot, et al.
Veröffentlicht: (2024)

Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”
Veröffentlicht: (2025)

Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
von: Emmanuelle A. D. Schindler, et al.
Veröffentlicht: (2025)

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
von: Nathaniel M. Schuster, et al.
Veröffentlicht: (2025)

The role of stress in the comorbidity of migraine and other chronic primary pain
von: Shi‐Jie Zhao, et al.
Veröffentlicht: (2025)

Driving evidence to practice for management of migraine in the emergency department: A systematic approach to guideline implementation
von: Jennifer Robblee, et al.
Veröffentlicht: (2026)

Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
von: Jonathan R. Treadwell, et al.
Veröffentlicht: (2025)

Memantine as a migraine prophylactic agent in adolescents: A retrospective analysis
von: M. Ismail K. Yousaf, et al.
Veröffentlicht: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
von: Rikki Mangrum, et al.
Veröffentlicht: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
von: Yunus Emre Meydanal, et al.
Veröffentlicht: (2025)

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
von: Stephen D. Silberstein, et al.
Veröffentlicht: (2024)

Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials
von: Jennifer Robblee, et al.
Veröffentlicht: (2024)

Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial
von: Serena Laura Orr, et al.
Veröffentlicht: (2024)

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
von: Koichi Ikeda, et al.
Veröffentlicht: (2025)

The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure
von: Tzu‐Hsuan Su, et al.
Veröffentlicht: (2024)

Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
von: Anna Gryglas‐Dworak, et al.
Veröffentlicht: (2024)

Evaluating associations of migraine‐related vertigo
von: Nazia Karsan, et al.
Veröffentlicht: (2025)

Partial rebreathing is not effective for early treatment of migraine with aura attacks: Results of a double‐blind, randomized, controlled trial ( PAREMA1 )
von: Charly Gaul, et al.
Veröffentlicht: (2025)

Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo‐controlled clinical trials
von: Larry Charleston, et al.
Veröffentlicht: (2026)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
von: Jessica Ailani, et al.
Veröffentlicht: (2024)

Afterimage duration differs for migraine with or without aura
von: Florian Rimmele, et al.
Veröffentlicht: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
von: Rebecca Erwin Wells, et al.
Veröffentlicht: (2024)

Useful considerations for treating migraine in patients with autism
von: Sinifunanya E. Nwaobi
Veröffentlicht: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
von: Gabriel Camargo de Oliveira, et al.
Veröffentlicht: (2026)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
von: Inga Zalia Tummoszeit, et al.
Veröffentlicht: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
von: Chia‐Chun Chiang, et al.
Veröffentlicht: (2024)

Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies
von: Guoliang Zhu, et al.
Veröffentlicht: (2024)

Machine learning models and classification algorithms in the diagnosis of vestibular migraine: A systematic review and meta‐analysis
von: Pablo D. Suarez‐Barcena, et al.
Veröffentlicht: (2025)

Counting the cost: How migraine shapes lives and economies
von: Risako Shirane, et al.
Veröffentlicht: (2025)

Cardiovascular risk and triptan usage among patients with migraine
von: Ido Peles, et al.
Veröffentlicht: (2025)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
von: Amy A. Gelfand
Veröffentlicht: (2024)

Cognitive and emotional mechanisms underlying migraine quality of life
von: Shiri Shinan‐Altman, et al.
Veröffentlicht: (2026)